These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 2535969)

  • 1. The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA.
    Andersson HC; Kihlman BA
    Carcinogenesis; 1989 Jan; 10(1):123-30. PubMed ID: 2535969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repair inhibition in the G1 phase of clastogen-treated human lymphocytes on the frequencies of chromosome-type and chromatid-type aberrations and sister-chromatid exchanges.
    Kishi K
    Mutat Res; 1987 Jan; 176(1):105-16. PubMed ID: 3796655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
    Darroudi F; Natarajan AT
    Mutat Res; 1989 Jun; 212(2):137-48. PubMed ID: 2543922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro.
    Kao-Shan CS; Micetich K; Zwelling LA; Whang-Peng J
    Cancer Treat Rep; 1984; 68(7-8):989-97. PubMed ID: 6204755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clastogenic action of ellipticine over the cell cycle of human lymphocytes and influence of posttreatments with caffeine and ara-C at G2.
    Sakamoto-Hojo ET; Takahashi CS
    Mutat Res; 1991 May; 248(1):195-202. PubMed ID: 2030708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.
    Backer LC; Allen JW; Harrington-Brock K; Campbell JA; DeMarini DM; Doerr CL; Howard DR; Kligerman AD; Moore MM
    Mutagenesis; 1990 Nov; 5(6):541-7. PubMed ID: 2175833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of G2 treatments with inhibitors of DNA synthesis and repair on chromosome damage induced by X-rays and chemical clastogens in root tips of Vicia faba. Comparison with corresponding effects in cultured human lymphocytes.
    Andersson HC; Kihlman BA
    Mutat Res; 1987 Nov; 181(1):173-85. PubMed ID: 3670323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of the frequency of chromatid aberrations in cultured human lymphocytes by combinations of inhibitors of DNA repair.
    Kihlman BA; Andersson HC
    Mutat Res; 1985; 150(1-2):313-25. PubMed ID: 3923342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The yield of fission neutron-induced chromatid aberrations in G2-stage human lymphocytes: effect of caffeine, hydroxyurea and cytosine arabinoside post-irradiation.
    Antoccia A; Palitti F; Raggi T; Catena C; Tanzarella C
    Int J Radiat Biol; 1992 Nov; 62(5):563-70. PubMed ID: 1361513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle traverse in AHH-1 tk +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa.
    Morris SM; McGarrity LJ; Domon OE; Chen JJ; Casciano DA
    Environ Mol Mutagen; 1996; 27(1):10-8. PubMed ID: 8625943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation using inhibition of G2 repair of the molecular basis of lesions which result in chromosomal aberrations.
    Moore RC; Randell C; Bender MA
    Mutat Res; 1988 May; 199(1):229-33. PubMed ID: 3129653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of chromosomal aberrations and SCEs by visible light in combination with dyes. II. Cell cycle dependence, and the effect of hydroxyl radical scavengers during light exposure in cultures of Chinese hamster ovary cells sensitized with acridine orange.
    Uggla AH
    Mutat Res; 1990 Aug; 231(2):233-42. PubMed ID: 2166908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analyses of the induction of chromosome aberrations and sister-chromatid exchanges in human lymphocytes exposed to gamma-rays and mitomycin-C in combination.
    Iijima K; Morimoto K
    Mutat Res; 1991 Aug; 263(4):263-8. PubMed ID: 1907353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-treatment effects of DNA topoisomerase inhibitors on UVB- and X-ray-induced chromosomal aberration formations.
    Ishii Y; Ikushima T
    Mutat Res; 2002 Jul; 504(1-2):67-74. PubMed ID: 12106647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I.
    Degrassi F; De Salvia R; Tanzarella C; Palitti F
    Mutat Res; 1989 Mar; 211(1):125-30. PubMed ID: 2537925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells xrs 5 and xrs 6. III. Induction of cell killing, chromosomal aberrations and sister-chromatid exchanges by bleomycin, mono- and bi-functional alkylating agents.
    Darroudi F; Natarajan AT
    Mutat Res; 1989 Jun; 212(2):123-35. PubMed ID: 2471928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of chromosomal aberrations and SCE by chloramphenicol.
    Sbrana I; Caretto S; Rainaldi G; Loprieno N
    Mutat Res; 1991 May; 248(1):145-53. PubMed ID: 2030703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-stage dependence of the formation of SCEs and chromosomal aberrations.
    Ishii Y; Watatani M
    Basic Life Sci; 1984; 29 Pt A():173-80. PubMed ID: 6442568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-stage dependence of mutagen-induced sister-chromatid exchanges in human lymphocyte cultures.
    Iijima K; Morimoto K
    Mutat Res; 1986 Aug; 162(1):121-9. PubMed ID: 3088441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes.
    Ribas G; Xamena N; Creus A; Marcos R
    Mutat Res; 1996 Jul; 368(3-4):205-11. PubMed ID: 8692226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.